Patents by Inventor Massimiliano Biagini

Massimiliano Biagini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions for immunising against
    Patent number: 10195263
    Abstract: An effective Staphylococcus aureus vaccine may require several antigenic components, and so various combinations of S. aureus antigens are identified for use in immunisation. These polypeptides may optionally be used in combination with S. aureus saccharides.
    Type: Grant
    Filed: May 8, 2017
    Date of Patent: February 5, 2019
    Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Fabio Bagnoli, Massimiliano Biagini, Luigi Fiaschi, Guido Grandi, Ravi Pratap Narayan Mishra, Nathalie Norais, Maria Scarselli
  • COMPOSITIONS FOR IMMUNISING AGAINST STAPHYLOCOCCUS AUREUS
    Publication number: 20170340720
    Abstract: An effective Staphylococcus aureus vaccine may require several antigenic components, and so various combinations of S. aureus antigens are identified for use in immunisation. These polypeptides may optionally be used in combination with S. aureus saccharides.
    Type: Application
    Filed: May 8, 2017
    Publication date: November 30, 2017
    Applicant: GlaxoSmithKline Biologicals SA
    Inventors: Fabio BAGNOLI, Massimiliano BIAGINI, Luigi FIASCHI, Guido GRANDI, Ravi Pratap Narayan MISHRA, Nathalie NORAIS, Maria SCARSELLI
  • Compositions for immunising against
    Patent number: 9642904
    Abstract: An effective Staphylococcus aureus vaccine may require several antigenic components, and so various combinations of S. aureus antigens are identified for use in immunisation. These polypeptides may optionally be used in combination with S. aureus saccharides.
    Type: Grant
    Filed: December 7, 2015
    Date of Patent: May 9, 2017
    Assignee: GlaxoSmithKline Biologicals SA
    Inventors: Fabio Bagnoli, Massimiliano Biagini, Luigi Fiaschi, Guido Grandi, Ravi Pratap Narayan Mishra, Nathalie Norais, Maria Scarselli
  • COMPOSITIONS FOR IMMUNISING AGAINST STAPHYLOCOCCUS AUREUS
    Publication number: 20160158335
    Abstract: An effective Staphylococcus aureus vaccine may require several antigenic components, and so various combinations of S. aureus antigens are identified for use in immunisation. These polypeptides may optionally be used in combination with S. aureus saccharides.
    Type: Application
    Filed: December 7, 2015
    Publication date: June 9, 2016
    Applicant: GlaxoSmithKline Biologicals SA
    Inventors: Fabio BAGNOLI, Massimiliano BIAGINI, Luigi FIASCHI, Guido GRANDI, Ravi Pratap Narayan MISHRA, Nathalie NORAIS, Maria SCARSELLI
  • Compositions for immunising against
    Patent number: 9205142
    Abstract: An effective Staphylococcus aureus vaccine may require several antigenic components, and so various combinations of S. aureus antigens are identified for use in immunization. These polypeptides may optionally be used in combination with S. aureus saccharides.
    Type: Grant
    Filed: February 3, 2014
    Date of Patent: December 8, 2015
    Assignee: GlaxoSmithKline Biologicals SA
    Inventors: Fabio Bagnoli, Massimiliano Biagini, Luigi Fiaschi, Guido Grandi, Ravi Pratap Narayan Mishra, Nathalie Norais, Maria Scarselli
  • STAPHYLOCOCCUS AUREUS SDRE CNAB DOMAIN AND ITS USE FOR VACCINATION
    Publication number: 20150273041
    Abstract: The S. aureus Ser-Asp rich fibrinogen/bone sialoprotein-binding protein contains three CnaB domains, and that the third of these provides significant protection against S. aureus infection. Thus a useful S. aureus vaccine can include a SdrE CnaB domain. Furthermore, the SdrE protein has been shown to be relatively resistant to trypsin digestion, which could be connected to the observation that SdrE contains an isopeptide bond within the third CnaB domain.
    Type: Application
    Filed: October 29, 2013
    Publication date: October 1, 2015
    Inventors: Andrea Guido Oreste Manetti, Luigi Fiaschi, Marco Becherelli, Prachi Prachi, Massimiliano Biagini
  • COMPOSITIONS FOR IMMUNISING AGAINST STAPHYLOCOCCUS AUREUS
    Publication number: 20140178425
    Abstract: An effective Staphylococcus aureus vaccine may require several antigenic components, and so various combinations of S. aureus antigens are identified for use in immunisation. These polypeptides may optionally be used in combination with S. aureus saccharides.
    Type: Application
    Filed: February 3, 2014
    Publication date: June 26, 2014
    Applicant: NOVARTIS AG
    Inventors: Fabio BAGNOLI, Massimiliano BIAGINI, Luigi FIASCHI, Guido GRANDI, Ravi Pratap Narayan MISHRA, Nathalie NORAIS, Maria SCARSELLI
  • Compositions for immunising against
    Patent number: 8679505
    Abstract: An effective Staphylococcus aureus vaccine may require several antigenic components, and so various combinations of S. aureus antigens are identified for use in immunization. These polypeptides may optionally be used in combination with S. aureus saccharides.
    Type: Grant
    Filed: April 14, 2010
    Date of Patent: March 25, 2014
    Assignee: Novartis AG
    Inventors: Fabio Bagnoli, Massimiliano Biagini, Luigi Fiaschi, Guido Grandi, Ravi Pratap Narayan Mishra, Nathalie Norais, Maria Scarselli
  • COMPOSITIONS FOR IMMUNISING AGAINST STAPHYLOCOCCUS AUREUS
    Publication number: 20120093850
    Abstract: Staphylococcus aureus Hla polypeptides having various deletions, insertions, and/or mutations which are useful for immunisation are provided herein. Also provided herein are Hla heptamers which are non-haemolytic. Additionally, an effective Staphylococcus aureus vaccine may require several antigenic components, and so various combinations of S. aureus antigens, including Hla polypeptides having deletions, insertions, and/or mutations, are identified for use in immunisation. These polypeptides may optionally be used in combination with S. aureus saccharides.
    Type: Application
    Filed: September 15, 2011
    Publication date: April 19, 2012
    Applicant: NOVARTIS AG
    Inventors: Fabio BAGNOLI, Massimiliano Biagini, Luigi Fiaschi, Guido Grandi, Ravi Pratap Narayan Mishra, Nathalie Norais, Maria Scarselli